China Infectious Respiratory Disease Diagnostics Market Size & Outlook
China infectious respiratory disease diagnostics market, 2018-2030 (US$M)
Related Markets
China infectious respiratory disease diagnostics market highlights
- The China infectious respiratory disease diagnostics market generated a revenue of USD 3,290.5 million in 2020 and is expected to reach USD 3,638.2 million by 2028.
- The China market is expected to grow at a CAGR of 1.3% from 2021 to 2028.
- In terms of segment, consumables was the largest revenue generating product in 2020.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Infectious respiratory disease diagnostics market data book summary
| Market revenue in 2020 | USD 3,290.5 million |
| Market revenue in 2028 | USD 3,638.2 million |
| Growth rate | 1.3% (CAGR from 2020 to 2028) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Services |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
Other key industry trends
- In terms of revenue, China accounted for 9.1% of the global infectious respiratory disease diagnostics market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, India infectious respiratory disease diagnostics market is projected to lead the regional market in terms of revenue in 2028.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 680.9 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Respiratory Disease Diagnostics Market Scope
Infectious Respiratory Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China infectious respiratory disease diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 65.09% in 2024. Horizon Databook has segmented the China infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
China is focusing on developing novel technologies and improving R&D activities to enhance its existing healthcare facilities. With its growing population comes the need for higher healthcare expenditure.
The need for early diagnosis of diseases to reduce treatment costs and mortality rate is expected to fuel the demand for infectious respiratory disease diagnostics. This can help save national income and improve patient outcomes.
The number of new cases of tuberculosis, influenza, and COVID-19 has reduced and most of its patients have recovered. According to WHO, new cases of tuberculosis were reported to be around 833,000 in 2019 from 889,000 in 2017.
Reasons to subscribe to China infectious respiratory disease diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China infectious respiratory disease diagnostics market databook
-
Our clientele includes a mix of infectious respiratory disease diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into China infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China infectious respiratory disease diagnostics market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
